FAP and neoplasm: However, the findings of a further study have indicated that the presence of highly reactive FAP-specific CAR-modified T cells can promote severe cachexia and dose-limiting bone toxicity without significantly affecting tumor suppression among different syngeneic tumor implantation models in mice.